EDIT:NASDAQ
Editas Medicine Inc
2,17 US$
arrow_upward
+1,40%(+0,030) 1K
13-noy, 16:00:01 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
2,14 US$
Yuqori
2,21 US$
Past
2,01 US$
Bozor kapitali
334,92 mln
Oʻrtacha hajm
2,42 mln
Hajmi
2,79 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Ochish
2,14 US$
Yuqori
2,21 US$
Past
2,01 US$
Bozor kapitali
334,92 mln
Oʻrtacha hajm
2,42 mln
Hajmi
2,79 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Bloomberg.com
·
1 soat oldin
Asian Stocks Brace for AI Pressure, Data Dump: Markets Wrap
Foreign Policy Journal
·
1 soat oldin
Nasdaq's Best Two-Month Week Ends With A Key-Level Failure As Nvidia (NASDAQ: NVDA) Earnings And Anthropic IPO Approach
investingLive
·
1 soat oldin
US futures open firmer as Nasdaq leads, oil slips despite Iran tanker claims: 5 things
Investor's Business Daily
·
2 soat oldin
Dow Jones Futures Due; How Will Nvidia React As Jensen Huang Mulls Return?
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida
CEO-
Xodimlar soni87
Asos solingannoy 2013
Bosh ofislar-
SektorHealth Care
Soha-
Veb-sayteditasmedicine.com